LUCD — Lucid Diagnostics Share News
0.000.00%
- $206.03m
- $213.49m
- $4.71m
Lucid Diagnostics Inc reports results for the quarter ended March 31 - Earnings Summary
Lucid Diagnostics Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: NCI-Sponsored Study Shows Positive Data For Lucid Diagnostics' Esoguard® Esophageal Dna Test In Patients Without Symptomatic Gerd
Brief: Lucid Diagnostics Announces Closing Of Public Offering Of Common Stock
U.S. STOCKS ON THE MOVE-JPMorgan Chase, Capri, Novavax
U.S. STOCKS ON THE MOVE-AppLovin, Ligand Pharma, Dexcom
U.S. STOCKS ON THE MOVE-CarMax, Red Cat, Lucid Diagnostics
U.S. STOCKS ON THE MOVE-Ford Motor, General Motors, AES
Lucid Diagnostics tumbles on deep-discounted share sale
Brief: Lucid Diagnostics Announces Pricing Of Public Offering Of Common Stock
Lucid Diagnostics tumbles on stock offering unveil
Brief: Lucid Diagnostics Announces Proposed Public Offering Of Common Stock
Lucid Diagnostics Inc reports results for the quarter ended December 31 - Earnings Summary
Lucid Diagnostics Inc expected to post a loss of 19 cents a share - Earnings Preview
Brief: Lucid Diagnostics Announces Closing of $15.3 Million Registered Direct Offering
Brief: Lucid Diagnostics Inc Announces $15.3 Million Registered Direct Offering
Brief: Lucid Diagnostics Announces $15.3 Million Registered Direct Offering
Brief: PAVmed Regains Compliance With Nasdaq Stockholders' Equity Requirement
Lucid Diagnostics Inc reports results for the quarter ended September 30 - Earnings Summary